Evidence map›Paper›PMID 38469558›Full record

ArticleFrontiers in immunology2023

Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report.

Jessica S Kleer, Lillemor Skattum, Denise Dubler, Ingeborg Fischer, Armin Zgraggen, Esther Mundwiler, Min Jeong Kim, Marten Trendelenburg

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genetic diagnosis of the Ehlers-Danlos syndromes.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jessica S KleerLaboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Lillemor SkattumDepartment of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, and Clinical Immunology and Transfusion Medicine, Region Skåne, Lund, Sweden.
Denise DublerLaboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Ingeborg FischerDivision of Pathology, Cantonal Hospital Aarau, Aarau, Switzerland.
Armin ZgraggenDivision of Rheumatology, Cantonal Hospital Aarau, Aarau, Switzerland.
Esther MundwilerDivision of Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland.
Min Jeong Kim *Division of Nephrology , Cantonal Hospital Aarau, Aarau, Switzerland.
Marten Trendelenburg *Laboratory of Clinical Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Kantonsspital Aarau · CHUniversity of Basel · CHLund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deficiencies of the early complement components of the classical pathway (CP) are well-documented in association with systemic lupus erythematosus (SLE) or SLE-like syndromes and severe pyogenic infections. Among these, complete C1s deficiency has been reported in nine cases so far. Here, we describe a 34-year-old male patient who presented with severe, recurrent infections since childhood, including meningitides with pneumococci and meningococci, erysipelas, subcutaneous abscess, and recurrent infections of the upper airways. The patient also exhibited adult-onset SLE, meeting 7/11 of the ACR criteria and 34 of the 2019 EULAR/ACR classification criteria, along with class IV-G (A) proliferative lupus nephritis (LN). A screening of the complement cascade showed immeasurably low CH50, while the alternative pathway (AP) function was normal. Subsequent determination of complement components revealed undetectable C1s with low levels of C1r and C1q, normal C3, and slightly elevated C4 and C2 concentrations. The patient had no anti-C1q antibodies. Renal biopsy showed class IV-G (A) LN with complement C1q positivity along the glomerular basement membranes (GBMs) and weak deposition of IgG, IgM, and complement C3 and C4 in the mesangium and GBM. In an ELISA-based functional assay determining C4d deposition, the patient's absent complement activity was fully restored by adding C1s. The genome of the patient was analyzed by whole genome sequencing showing two truncating variants in the

Indexed as

Complement C1sHereditary Complement Deficiency DiseasesLupus Erythematosus, SystemicLupus NephritisAdultCodon, NonsenseComplement C1qHumansMaleNucleotidesReinfectionCodon, NonsenseComplement C1qComplement C1sNucleotidescomplement C1simmunodeficiency diseaseslupus nephritis (LN)non-sense mutationsystemic lupus erythematosus (SLE)

Identifiers

PMID38469558
PMCPMC10925646
OpenAlexW4392165449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.